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*HLA‐B\*44:138Q* characterised by recombination and unique deletion events. *The name B\*44:138Q* has been officially assigned by the WHO Nomenclature Committee in October 2011. This follows the agreed policy that, subject to the conditions in the most recent Nomenclature Report,[14](#tan13439-bib-0014){ref-type="ref"} names will be assigned to new sequences as they are identified. Lists of such new names will be published in the following WHO Nomenclature Report.

 {#tan13439-sec-0001}

Low resolution HLA‐typing of a patient indicated the existence of a novel allele. We proceeded by performing high‐resolution typing by sequencing. Because the characterisation of the new allele required full length sequence analysis, we performed Sanger sequencing on cloned long‐range polymerase chain reaction (PCR) products or amplicons generated by allele specific primers. The advent of next‐generation sequencing (NGS) allowed us to assess the comparability of both methods in respect to effort and reliability of data on this new sequence. Biochemical tests for expression of the new allele were impossible because of lack of material. However, serological analyses were applied to check the expression of HLA epitopes on the cell surface.

Both techniques, SSO and SSP, led to inconclusive results in the HLA‐B typing of an human immunodeficiency virus‐positive patient; the most probable genotype seemed *HLA‐B\*07*,\**44.* Subsequent Sanger sequencing of exons 1, 2, and 3 revealed a heterozygous genotype consisting of an *HLA‐B\*07:02*, and a novel *HLA‐B\*44* related allele; thus, refining the initial findings. The sequence of the new allele could be perfectly aligned with *HLA‐B\*44:02:01:01*; there was a deletion of three bases at codon 94, although.

To exclude phasing artefacts, we extended the analyses by cloning and sequenced 20 clones spanning exons 1 to 3. By this strategy, the results from the heterozygous sequencing were confirmed.

To characterise the novel allele more comprehensively, we amplified the whole novel allele by long‐range PCR using allele specific primers located in the 5′ and 3′ end of the gene. For Sanger sequence analyses, we used 11 sequencing primers (all oligonucleotides of this study are listed in Table [1](#tan13439-tbl-0001){ref-type="table"}) that created overlapping sequences of forward and reverse strands.

###### 

Oligonucleotides used for sequencing based HLA typing with Sanger or next‐generation sequencing (NGS) technology

  Designation                                                         Sequence (5′‐ \>3′)                           Coverage                  Reference                                 Sequencing technology
  ------------------------------------------------------------------- --------------------------------------------- ------------------------- ----------------------------------------- -----------------------
  A. Primers used for polymerase chain reaction (PCR)‐amplification                                                                                                                     
  *5BIN1CG\**                                                         CGG GGG CGC AGG ACC CGG                       HLA‐B, Int1 ‐ Ex3         [1](#tan13439-bib-0001){ref-type="ref"}   Sanger
  *3BIn3‐37\**                                                        AGG CCA TCC CCG SCG ACC TAT                                             [1](#tan13439-bib-0001){ref-type="ref"}   
  *CL1‐14AMp‐B1\**                                                    CGA GGA TGC GGG TCA CGG C                     HLA‐B, Ex1‐Ex2            In house                                  Sanger
  *CL1‐320G rev\**                                                    CCT CGC TCT GGT TGT AGT AGC                                             In house                                  
  *B\*44‐‐18fwd*\*                                                    GCA CCC ACC CGG ACT CAG AA                    HLA‐B, full length        In house                                  Sanger
  *B\*44‐4347rev*\*                                                   GGG GTC ACG GTG GAC ACG G                                               In house                                  
  A‐F1fwd                                                             AAC TCA GAG CTA AGG AAT GAT GGC AAA T         HLA‐A, full length        [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  A‐F2 fwd                                                            AAC TCA GAG CTA TGG AAT GAT GGT AAA T                                   [2](#tan13439-bib-0002){ref-type="ref"}   
  A‐R1 rev                                                            ATA TAA CCA TCA TCG TGT CCC AAG GTT C                                   [2](#tan13439-bib-0002){ref-type="ref"}   
  B‐5'UTR fwd                                                         GGC AGA CAG TGT GAC AAA GAG GC                HLA‐B, full length        [3](#tan13439-bib-0003){ref-type="ref"}   NGS
  B‐3'UTR‐3769                                                        CTG CCC CAG CAC ACT GCA GC                                              In house                                  
  C‐5'UTR fwd                                                         TCA GGC ACA CAG TGT GAC AAA GAT               HLA‐C, full length        [3](#tan13439-bib-0003){ref-type="ref"}   NGS
  C‐3'UTR‐3779                                                        CTG CAG CAC ACR ATC AGG TTT C                                           In house                                  
  DQB1‐453 fwd                                                        TGA CAG CAA TTT TCT CTC CCC TGA               HLA‐DQB1, full length     [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  *DQB1\*04Ex1* fwd                                                   ATG TCT TGG AAG AAG GCT TTG CG                                          In house                                  
  DQB1‐6495 rev                                                       TGG GGA TGA AAG GAG ATG ACC TG                                          [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐F1                                                         CTG CTG CTC CTT GAG GCA TCC ACA               HLA‐DRB1, 5'UTR‐Exon2     [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  DRB1‐PE2‐F2                                                         CTG CTA CTC CTT GAG GCA TCC ACA                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐F3                                                         CTG CTG CTC CCT GAG GCA TCC ACA                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐R1                                                         CTT CTG GCT GTT CCA GTA CTC GGC AT                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐R2                                                         CTT CTG GCT GTT CCA GGA CTC GGC GA                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐R3                                                         CTT CTG GCT GTT CCA GTA CTC AGC GT                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐R4                                                         CTT CTG GCT GTT CCA GTA CTC CTC AT                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐R5                                                         CTT CTG GCT GTT CCA GTG CTC CGC AG                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐PE2‐R6                                                         CTT CTG GCT GTT CCA GTA CTC GGC GC                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐1.1‐F                                                       GCA CGT TTC TTG TGG CAG CTT AAG TT            HLA‐DRB1, Exon2‐3'UTR     [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  DRB1‐E2‐1.2‐F                                                       GCA CGT TTC TTG TGG CAG CTA AAG TT                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐2‐F                                                         TTT CCT GTG GCA GCC TAA GAG G                                           [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐3568‐F                                                      CAC AGC ACG TTT CTT GGA GTA CTC                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐4‐F                                                         AGC ACG TTT CTT GGA GCA GGT TAA ACA                                     [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐7‐F4                                                        CAC AGC ACG TTT CCT GTG GCA GGG                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐9‐F                                                         CAC AGC ACG TTT CTT GAA GCA GGA                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐10‐F                                                        ACA GCA CGT TTC TTG GAG GAG GT                                          [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐12‐R                                                        ATG CAC GGG AGG CCA TAC GGT                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐3568‐R                                                      ATG CAC AGG AGG CCA TAG GGT                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐4‐R                                                         ATG CAT GGG AGG CAG GAA GCA                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐7‐R2                                                        CAG ATG CAT GGG AGG CAG GAA GCG                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐9‐R                                                         ATG CAT GGG AGG CAG GAA GCG                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐E2‐10‐R                                                        TGG AAT GTC TAA AGC AAG CTA TTT AAC ATA TGT                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB1‐5'UTR                                                          TCT GGC CCC TGG TCC TGT CCT GTT CTC CAG GG    HLA‐DRB1, full length     In house                                  NGS
  DRB1‐3'UTR                                                          TGC TGA ACC AGT AGC AAC CAG GTC C                                       In house                                  
  DQA1fwd‐310                                                         AGA CAT GCA CAC ACC AGA GAA GA                HLA‐DQA1, full length     In house                                  NGS
  DQA1rev‐5441                                                        TGC CAC TTC CCA ATT CCC CTA C                                           In house                                  
  DPB1‐PRO‐F2                                                         CCT CCT GAC CCT GAT GAC AGT CCT               HLA‐DPB1, 5'UTR‐Exon2     [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  DPB1‐PRO‐R2                                                         CCA TCT GCC CCT CAA GCA CCT CAA                                         [2](#tan13439-bib-0002){ref-type="ref"}   
  DPB1‐F2                                                             CTC AGT GCT CGC CCC TCC CTA GTG AT            HLA‐DPB1, Exon2‐3'UTR     [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  DPB1‐R2                                                             GCA CAG TAG CTT TCG GGA ATT GAC CA                                      [2](#tan13439-bib-0002){ref-type="ref"}   
  *DRB3‐In1fwd\*01*                                                   GTG TGA CCG GAT CCT TCG TGT A                 HLA‐DRB3, Intron1‐3'UTR   In house                                  NGS
  *DRB3‐In1fwd\*02*                                                   GTG TGA CCG GAG CAT TCG TGT C                                           In house                                  
  DRB3‐E2‐R1                                                          ATG CAC AGG AGG CCA TAG GGT                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB5‐In1fwd                                                         ATG GCG GCG TCT CTG TCA GTA                   HLA‐DRB5, Intron1‐3'UTR   In house                                  NGS
  DRB5‐E2‐R                                                           ATG CAT GGG AGG CCG TAG GGT                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DRB4‐In1fwd                                                         CCG GAT CGT TCG TGT CCC CA                    HLA‐DRB4, Intron1‐3'UTR   In house                                  NGS
  DRB4‐E2‐R                                                           ATG CAT GGG AGG CAG GAC AGT                                             [2](#tan13439-bib-0002){ref-type="ref"}   
  DPA1‐F1                                                             CTC TCT TGA CCA CGC TGG TAC CTA               HLA‐DPA1, full length     [2](#tan13439-bib-0002){ref-type="ref"}   NGS
  DPA1‐R1                                                             TTG GCC TCT TGG CTA TAC CTC TTT T                                       [2](#tan13439-bib-0002){ref-type="ref"}   
  E‐fwd (E08072)                                                      CAG CGT CGC CAC GAC TCC CGA C                 HLA‐E, full length        [4](#tan13439-bib-0004){ref-type="ref"}   NGS
  E‐rev (E10034)                                                      AGA CAC AGA GGT GGA CTG TTT CTC T                                       [4](#tan13439-bib-0004){ref-type="ref"}   
  G‐5'UTR260‐fwd                                                      GAA GTC CCA GGG CCT CAA GC                    HLA‐G, full length        In house                                  NGS
  G‐rev 3228                                                          CCC ATC AAT CTC TCT TGG AAA                                             In house                                  
  MICA‐fwd Ex1                                                        ACG CGT TGT CTG TCC TGG AA                    MICA‐exon 1‐Exon2         [5](#tan13439-bib-0005){ref-type="ref"}   NGS
  MICA‐rev RG                                                         CTA CGA CGG GGG TAA GGG AAG GGT T                                       [6](#tan13439-bib-0006){ref-type="ref"}   
  MICA‐fwd FG                                                         CGT TCT TGT CCC TTT GCC CGT GTG C             MICA‐Exon2‐3'UTR          [6](#tan13439-bib-0006){ref-type="ref"}   NGS
  MICA‐rev 3'UTR                                                      CGT GCC TGG CCT GAG ACT                                                 [7](#tan13439-bib-0007){ref-type="ref"}   
  B. Primers used for sequencing                                                                                                                                                        
  *B\*44‐559* rev                                                     TCG TCC ACG TAG CCC ACG GT                    *HLA‐B\*44 559*           In house                                  Sanger
  *B\*44‐1034fwd*                                                     GGG TCT CAC ATC ATC CAG AGG                   *HLA‐B\*44 1034*          In house                                  Sanger
  *B\*44‐1830fwd*                                                     GTC CTA GGG TGT CCC ATG AG                    *HLA‐B\*44 1830*          In house                                  Sanger
  *B\*44‐2155rev*                                                     GAA GAG ATA TGA CCC CTC ATC C                 *HLA‐B\*44 2155*          In house                                  Sanger
  *B\*44‐2182fwd*                                                     CTG GAG CCC TTC AGC AGG                       *HLA‐B\*44 2182*          In house                                  Sanger
  *B\*44‐2346fwd*                                                     TGT GAT GTG TAG GAG GAA GAG C                 *HLA‐B\*44 2346*          In house                                  Sanger
  *B\*44‐2797fwd*                                                     TCC CAG TCC CCT CAC AGG G                     *HLA‐B\*44 2797*          In house                                  Sanger
  *B\*44‐3041rev*                                                     CCC ACC CAC CCC CAG ACC T                     *HLA‐B\*44 3041*          In house                                  Sanger
                                                                                                                                                                                        

A. Lists all primers used for the generation of sequencing templates by PCR. B. Lists all sequencing primers that have been used for full length Sanger sequencing of the *HLA‐B\*44*:138Q allele. In column "Designation" the names of the primers are listed; in column "Sequence (5′‐ \>3′)" the sequence of the nucleotides is provided; in column "Coverage" the targeted gene and the location of the primers on this gene are indicated; in column "Reference" the origin of the primer sequence is listed: primers have been created by us ("in house") or have been taken from publications; in column "Sequence technology" the technique used is stated. Oligonucleotides marked with \*are also used as sequencing primers. The primers have been positioned to allow a full coverage of the allele

To further confirm these results, we performed full‐length sequencing of HLA‐B alleles from the patient and all available family members by NGS.[8](#tan13439-bib-0008){ref-type="ref"} This approach covered even longer regions of the 5'UTR and 3'UTR than we had obtained in the Sanger approach.

The family study confirmed the unequivocal segregation of the new allele ( Figure [1](#tan13439-fig-0001){ref-type="fig"}).

![Pedigree chart of the patient\'s family; A‐D indicate HLA‐haplotypes; only HLA‐A, B, C, DRB1, and DQB1 genotypes at two field resolution are depicted for easy readability. The new allele is located on haplotype b*,* which is observed in the father and two siblings *\*the* mother was at the time of typing already deceased, her haplotypes have been deduced. The typing has been performed by various methods:Serology: we used 180 in house validated typing sera to detect HLA class I molecules on the cell surface.Low resolution typing: SSO typing was performed for *HLA‐A*, ‐*B*, and ‐*C* genes using a commercial reverse dot blot assay (Dynal, Bloomsborough, UK), SSP typing was performed for the *HLA B* gene only using a commercial SSP assay (Genovision, Vienna, UK).Sequencing‐based typing is described in Figure [2](#tan13439-fig-0002){ref-type="fig"}.The full characterisation of HLA‐haplotypes is as follows*:*\
Haplotype a*: G\*01:04:04*, *A\*23:01:01*, *E\*01:01:01:01*, *C\*04:01:01:01*, *B\*44:03:01:01*, *MICA\*004*, *DRB4\*01:01:01:01*, *DRB1\*07:01:01:01*, *DQA1\*02:01:01:01*, *DQB1\*02:02:01:01*, *DPA1\*01:03:01:04*, *DPB1\*04:01:01:01. Haplotype b: G\*01:01:01:05*, *A\*03:01:01:01*, *E\*01:03:02:01*, *C\*07:04:01:01*, *B\*44:138Q*, *MICA\*008:01:02*, *DRB5\*02:02*, *DRB1\*16:01:01*, *DQA1\*01:02:02*, *DQB1\*05:02:01*, *DPA1\*01:03:01:02*, *DPB1\*04:01:01:01. Haplotype c: G\*01:01:01:01*, *A\*02:01:01:01*, *E\*01:01:01:01*, *C\*07:02:02:03*, *B\*07:02:01*, *MICA\*008:04*, *DRB4\*01:03:01:01*, *DRB1\*04:01:01:01*, *DQA1\*03:01:01*, *DQB1\*03:02:01*, *DPA1\*01:03:01:02, DPB1\*04:01:01:01. Haplotype d: G\*01:01:01:01*, *A\*02:01:01:01, E\*01:03:02:01*, *C\*03:04:01:01*, *B\*40:01:02*, *MICA\*008:04*, *DRB3\*03:01:01*, *DRB1\*13:02:01*, *DQA1\*01:02:01:04*, *DQB1\*06:04:01*, *DPA1\*01:03:01:01*, *DPB1\*02:01:02:06*](TAN-93-89-g001){#tan13439-fig-0001}

To further characterise the haplotypes, we typed other class I genes, HLA‐A, C, E, and G and class II genes, HLA‐DRB1, DRB3/4/5, DQA1, DQB1, DPA1, and DPB1; additionally the class I‐related *MICA* genes were typed. All of those genes were typed at full length. The results are provided in Figure [1](#tan13439-fig-0001){ref-type="fig"}. All alleles observed have been listed in the database; it thus seems that the events, leading to the generation of the new HLA‐B allele did not affect other functional genes of the haplotype.

Restricting the view on the sequence to exons 1 to 3, the relationship of the novel allele with the *HLA‐B\*44* group seemed apparent: sequences were identical except the deletion of three nucleotides. After we had obtained the full length sequence, it became evident, that the region from the 5′ end to Intron 3 matched perfectly with *HLA‐B\*44:02:01:01* and other *HLA‐B\*44* alleles. From position 1620 in exon 4, however, several mismatches appeared; this part of the sequence matched perfectly with *HLA‐B\*15:18:01:02* (Figure [2](#tan13439-fig-0002){ref-type="fig"}), although. From position 1221 in intron 3 to position 1619 in exon 4 both putative founder alleles share the sequence, a recombination between the two alleles might therefore have occurred there.[9](#tan13439-bib-0009){ref-type="ref"} By contrast, the deletion of three nucleotides in exon 3 is a unique feature of *HLA‐B\*44:138Q*, indicating an independent event, that led to the creation of this allele.

![Sequence alignments of *HLA‐B\*44:138Q*, *HLA‐B\*44:02:01:01*, and *HLA‐B\*15:18:01:02.* Alignments have been generated using the tool of the IMGT/HLA database ([https://www.ebi.ac.uk/cgi‐bin/ipd/imgt/hla](https://www.ebi.ac.uk/cgi-bin/ipd/imgt/hla)), version 3.33.0. *Bases identical with HLA‐B\*44:138Q* are indicated by dashes, different nucleotides are marked, and deletions are signposted with dots; "\|" denotes exon/intron borders. The numbering of base positions in the genomic DNA (gDNA) is according to the IMGT/*database.* The *HLA‐B\*44:138Q* sequence was obtained by nucleotide Sanger sequencing (positions 22 to 456) and whole gene Sanger sequencing (positions −10 to 3034) or NGS (positions −284 to 3804). For the preparation of an amplification template for Sanger sequencing, primers for whole gene amplification were designed that covered the gene from its 5'UTR to the 3'UTR and separated *HLA‐B\*07* and *HLA‐B\*44* allele groups. For amplification the PCR Qiagen Long‐Range PCR Kit (Qiagen GmbH Hilden, Germany) was used. Sequencing was performed with overlapping primers for the whole *HLA‐B\*44* allele. All primers are listed in Table [1](#tan13439-tbl-0001){ref-type="table"}. Cycle sequencing was performed using a Big Dye Terminator Cycle Sequencing kit (ABI, Foster City, CA). The sequencing products were analysed on an ABI 3100 capillary sequencer. For confirmation, heterozygous PCR products spanning exons 1 to exons 3 were cloned with TA Cloning kit pCR 2.1 vector (Invitrogen, Carlsbad, USA) and also subjected to Sanger sequencing. For NGS analyses, long‐range amplification of the whole *HLA‐B* gene was achieved with the primers listed in Table [1](#tan13439-tbl-0001){ref-type="table"}. Amplification was performed using GoTaq Long PCR Mastermix (Promega Corporation, Woods Hollow Roads Madison). Library preparation was performed according to the manufacturers\' instructions. Size selection was performed on an E‐Gel (Invitrogen, Kiryat Shoma, Israel); only fragments with sizes \>400 bp were selected. After quantification, 26 PMol of fragments were used for emulsion PCR. Enriched Ion sphere particles were loaded onto a Ion Torrent 316 chip v2 (Life Technologies, Carlsbad, California) and subsequently sequenced on an Ion PGM device (LifeTechnologies, Carlsbad, California) with a flow number of 800, for 400 base reads. Analysis of the reads was performed using two different NGS analysis software packets (TypeStream NGS Analysis Software, One Lambda, Inc. Canoga Park CA; NGSengine, GenDX, Utrecht, The Netherlands)](TAN-93-89-g002){#tan13439-fig-0002}

In this respect, the new allele differs from the majority of other HLA alleles, where a simple "fixation of a single recombination event was responsible for the origin"[9](#tan13439-bib-0009){ref-type="ref"}; whether these events have occurred simultaneously or in independent meioses remains impossible to decide.

Because of the fact that this deletion comprised three nucleotides and occurred within two identical neighbouring codons (ATC‐ATC) the resulting protein was shortened by just one isoleucin. This deletion concerns the second domain at the edge between the α‐helix and the β‐sheet. It is not likely that this position is part of an epitope.[10](#tan13439-bib-0010){ref-type="ref"}, [11](#tan13439-bib-0011){ref-type="ref"} However, the conformation of the molecules might change which could involve modifications of serological epitopes. This assumption would be in concordance with results from lymphocytotoxic tests: sera specific for HLA‐B44 (n = 2), HLA‐B12 (n = 2), or Bw4 (n = 3) did not show any reactivities with cells of the *HLA‐B\*44:138Q*‐positive individual.

From a technical point, the analysis of the full‐length gene by NGS was much simpler than the Sanger approach, because of the clonal nature of the NGS sequencing, there was no necessity to separate alleles beforehand and no additional sequencing primers had to be designed. The sequence of the *HLA‐B\*44:138Q* allele was concordant with the Sanger result except a homopolymer at position 3061 of the 3'UTR: With the Sanger technique, 3 cytosins were detected while the consensus of the NGS analysis indicated only 2 cytosins. Given that Sanger sequencing has represented the golden standard for HLA typing for decades[12](#tan13439-bib-0012){ref-type="ref"} this discrepancy argues for a good concordance of the new technology, albeit we have compared only one of the several platforms.

In summary, the characterisation of *HLA‐B\*44:138Q* on the IonTorrent platform allowed a fast analysis of whole genes with much less effort compared with Sanger sequencing. However, the homopolymer issue[13](#tan13439-bib-0013){ref-type="ref"} of NGS remains a diagnostic challenge. The generation of the new allele within a haplotype that otherwise consists of common HLA‐alleles (as assessed by full length sequencing) indicates that the mechanisms leading to this new allele are restricted to a single gene.
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